Patents by Inventor Alan Schatzberg

Alan Schatzberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING DEPRESSION USING NCAM PEPTIDE MIMETICS
    Publication number: 20120277159
    Abstract: The present application relates to the treatment and diagnosis of mood disorders, including bipolar disorder, major depression disorder and schizophrenia. The invention provides novel diagnostic markers and assays, as well as research tools for the development and discovery of agents and compounds which are useful for treating patients who suffer from mental illness.
    Type: Application
    Filed: March 27, 2012
    Publication date: November 1, 2012
    Applicant: Board of Trustees of the Leland Stanford Junior University
    Inventors: Huda Akil, Stanley Watson, Cortney Turner, William Bunney, Edward Jones, Richard Myers, Alan Schatzberg
  • SNP DETECTION AND OTHER METHODS FOR CHARACTERIZING AND TREATING BIPOLAR DISORDER AND OTHER AILMENTS
    Publication number: 20110104674
    Abstract: The present application relates to the use of SNPs and differential exon expression to characterize, diagnose or treat bipolar disorder and other mental illnesses, such as major depressive disorder and schizophrenia.
    Type: Application
    Filed: April 20, 2010
    Publication date: May 5, 2011
    Applicant: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: HUDA AKIL, STANLEY J. WATSON, SIMON J. EVANS, CORTNEY TURNER, RENE BERNARD, ILAN KERMAN, ROBERT THOMPSON, MARGIT BURMEISTER, LAURA J. SCOTT, FAN MENG, MICHAEL BOEHNKE, WILLIAM BUNNEY, MARQUIS VAWTER, EDWARD JONES, PRABHAKARA V. CHOUDARY, RICHARD MYERS, ALAN SCHATZBERG, JUN LI, DEVIN ABSHER
  • FGF2-RELATED METHODS FOR DIAGNOSING AND TREATING DEPRESSION
    Publication number: 20090019557
    Abstract: The present application relates to the treatment and diagnosis of mood disorders, including bipolar disorder, major depression disorder and schizophrenia. The invention provides novel diagnostic markers and assays, as well as research tools for the development and discovery of agents and compounds which are useful for treating patients who suffer from mental illness.
    Type: Application
    Filed: November 13, 2006
    Publication date: January 15, 2009
    Inventors: Huda Akil, Stanley Watson, Simon Evans, Cortney Turner, Rene Bernard, Ilan Kerman, Robert C. Thompson, Margit Burmeister, Laura J. Scott, Fan Meng, Michael Boehnke, William Bunney, Marquis Vawter, Edward Jones, Prabhakara Choudary, Richard Myers, Alan Schatzberg, Jun Li, Devin Absher, Hiroaki Tomita
  • SNP DETECTION AND OTHER METHODS FOR CHARACTERIZING AND TREATING BIPOLAR DISORDER AND OTHER AILMENTS
    Publication number: 20080199866
    Abstract: The present application relates to the use of SNPs and differential exon expression to characterize, diagnose or treat bipolar disorder and other mental illnesses, such as major depressive disorder and schizophrenia.
    Type: Application
    Filed: October 5, 2007
    Publication date: August 21, 2008
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Huda Akil, Stanley J. Watson, Simon J. Evans, Cortney Turner, Rene Bernard, Ilan Kerman, Robert Thompson, Margit Burmeister, Laura J. Scott, Fan Meng, Michael Boehnke, William Bunney, Marquis Vawter, Edward Jones, Prabhakara V. Choudary, Richard Myers, Alan Schatzberg, Jun Li, Devin Absher
  • Methods and compositions for modulation of sleep cycle
    Publication number: 20070270393
    Abstract: Methods and compositions for modulating the circadian rhythm of a subject are provided. In practicing the subject methods, modulation of the circadian rhythm of a subject is achieved by administering to the subject an effective amount of at least one of a glucocorticoid receptor antagonist, a CRH antagonist and an MR agonist. Also provided are kits for practicing the subject methods.
    Type: Application
    Filed: February 15, 2007
    Publication date: November 22, 2007
    Inventors: Theresa Buckley, Alan Schatzberg
  • Method to determine the risk for side effects of an SSRI treatment in a person
    Publication number: 20060228750
    Abstract: A new method is found to determine an increased risk for side effects of an SSRI treatment in a person by genotyping the person for the presence of the 102 C/C DNA sequence in the 5-HT2A receptor gene. This provides for a method to improve the treatment of an SSRI responsive disorder and in particular depression.
    Type: Application
    Filed: June 8, 2006
    Publication date: October 12, 2006
    Inventors: Greer Murphy, Alan Schatzberg
  • Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder
    Publication number: 20060051786
    Abstract: The present invention provides methods for diagnosing mental disorders. The invention also provides methods of identifying modulators of mental disorders as well as methods of using these modulators to treat patients suffering from mental disorders.
    Type: Application
    Filed: June 21, 2005
    Publication date: March 9, 2006
    Applicant: The Board of Trustees of the Leland Stanford Junior University of Stanford
    Inventors: Huda Akil, William Bunney, Prabhakara Choudary, Simon Evans, Edward Jones, Jun Li, Juan Lopez, David Lyons, Margherita Molnar, Richard Myers, Alan Schatzberg, Richard Stein, Robert Thompson, Hiroaki Tomita, Marquis Vawter, Stanley Watson
  • Methods and compositions for predicting compliance with an antidepressant treatment regimen
    Publication number: 20050165115
    Abstract: Methods and compositions are provided for predicting whether a subject will comply with an antidepressant treatment regimen. In practicing the subject methods, a subject's serotonin transporter gene-linked polymorphic region (5HTTLPR) is genotyped. Based on the identified genotype, a particular antidepressant treatment regimen suitable for the patient is determined. Also provided are kits for practicing the subject methods.
    Type: Application
    Filed: December 9, 2004
    Publication date: July 28, 2005
    Inventors: Greer Murphy, Alan Schatzberg
  • Glucocorticoid blocking agents for increasing blood-brain barrier permeability stan-261con
    Publication number: 20050124533
    Abstract: Glucocorticoid blockers, including glucocorticoid receptor antagonists, are effective to prevent glucocorticoid-induced decrease in permeability of the blood-brain barrier and to increase the permeability of the blood-brain barrier. Administration of glucocorticoid blockers, including glucocorticoid receptor antagonists, concomitant with administration of drugs for treating diseases of the central nervous system increases delivery of such drugs into the central nervous system.
    Type: Application
    Filed: September 24, 2004
    Publication date: June 9, 2005
    Inventors: Alan Schatzberg, Steven Lindley, Joseph Belanoff